<SEC-DOCUMENT>0001104659-16-153912-index.html : 20161102
<SEC-HEADER>0001104659-16-153912.hdr.sgml : 20161102
<ACCEPTANCE-DATETIME>20161102070044
ACCESSION NUMBER:		0001104659-16-153912
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20161102
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161102
DATE AS OF CHANGE:		20161102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemphire Therapeutics Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		161966266

	BUSINESS ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
		BUSINESS PHONE:		248-980-6538

	MAIL ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a16-20876_18k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a16-20876_18k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a16-20876_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: a16-20876_1ex99d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g208761mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g208761mmi001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g208761mmi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g208761mmi002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g208761mmi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g208761mmi003.jpg

</DOCUMENT>
</SEC-DOCUMENT>